
# A Geometric Graph-Based Deep Learning Model for Drug-Target Affinity Prediction

**Korean Title:** ì•½ë¬¼-íƒ€ê²Ÿ ì¹œí™”ë„ ì˜ˆì¸¡ì„ ìœ„í•œ ê¸°í•˜ ê·¸ë˜í”„ ê¸°ë°˜ ë”¥ ëŸ¬ë‹ ëª¨ë¸ ìœ ì§€í•˜ê¸°

## ğŸ“‹ ë©”íƒ€ë°ì´í„°

**Links**: [[daily/2025-09-18|2025-09-18]] [[keywords/evolved/Multiscale Weighted Colored Bipartite Subgraphs|Multiscale Weighted Colored Bipartite Subgraphs]] [[keywords/broad/Deep Learning|Deep Learning]] [[keywords/broad/Geometric Graph|Geometric Graph]] [[keywords/specific/Attention Mechanism|Attention Mechanism]] [[keywords/unique/DeepGGL|DeepGGL]] [[categories/cs.LG|cs.LG]]

## ğŸ·ï¸ ì¹´í…Œê³ ë¦¬í™”ëœ í‚¤ì›Œë“œ
**ğŸš€ Evolved Concepts**: Multiscale Interactions
**ğŸ”¬ Broad Technical**: Deep Learning, Graph Learning
**ğŸ”— Specific Connectable**: Attention Mechanism
**â­ Unique Technical**: DeepGGL

**ArXiv ID**: [2509.13476](https://arxiv.org/abs/2509.13476)
**Published**: 2025-09-18
**Category**: cs.LG
**PDF**: [Download](https://arxiv.org/pdf/2509.13476.pdf)


## ğŸ·ï¸ ì¶”ì¶œëœ í‚¤ì›Œë“œ



`Deep Learning` â€¢ 

`Graph Neural Network` â€¢ 

`Attention Mechanism` â€¢ 

`DeepGGL` â€¢ 

`Multiscale Interaction Modeling`



## ğŸ“‹ ì €ì ì •ë³´

**Authors:** 

## ğŸ“„ Abstract (ì›ë¬¸)

arXiv:2509.13476v1 Announce Type: cross 
Abstract: In structure-based drug design, accurately estimating the binding affinity between a candidate ligand and its protein receptor is a central challenge. Recent advances in artificial intelligence, particularly deep learning, have demonstrated superior performance over traditional empirical and physics-based methods for this task, enabled by the growing availability of structural and experimental affinity data. In this work, we introduce DeepGGL, a deep convolutional neural network that integrates residual connections and an attention mechanism within a geometric graph learning framework. By leveraging multiscale weighted colored bipartite subgraphs, DeepGGL effectively captures fine-grained atom-level interactions in protein-ligand complexes across multiple scales. We benchmarked DeepGGL against established models on CASF-2013 and CASF-2016, where it achieved state-of-the-art performance with significant improvements across diverse evaluation metrics. To further assess robustness and generalization, we tested the model on the CSAR-NRC-HiQ dataset and the PDBbind v2019 holdout set. DeepGGL consistently maintained high predictive accuracy, highlighting its adaptability and reliability for binding affinity prediction in structure-based drug discovery.

## ğŸ” Abstract (í•œê¸€ ë²ˆì—­)

arXiv:2509.13476v1 ë°œí‘œ ìœ í˜•: êµì°¨
ìš”ì•½: êµ¬ì¡° ê¸°ë°˜ ì•½ë¬¼ ë””ìì¸ì—ì„œ í›„ë³´ ë¦¬ê°„ë“œì™€ ë‹¨ë°±ì§ˆ ìˆ˜ìš©ì²´ ê°„ì˜ ê²°í•© ì¹œí™”ë„ë¥¼ ì •í™•í•˜ê²Œ ì¶”ì •í•˜ëŠ” ê²ƒì€ ì¤‘ìš”í•œ ê³¼ì œì…ë‹ˆë‹¤. íŠ¹íˆ ìµœê·¼ ì¸ê³µ ì§€ëŠ¥, íŠ¹íˆ ë”¥ ëŸ¬ë‹ì˜ ë°œì „ì€ êµ¬ì¡° ë° ì‹¤í—˜ì  ì¹œí™”ë„ ë°ì´í„°ì˜ ì¦ê°€ë¡œ ê°€ëŠ¥í•´ì¡Œìœ¼ë©°, ì´ëŸ¬í•œ ì‘ì—…ì— ëŒ€í•´ ì „í†µì ì¸ ê²½í—˜ì  ë° ë¬¼ë¦¬í•™ ê¸°ë°˜ ë°©ë²•ë³´ë‹¤ ìš°ìˆ˜í•œ ì„±ëŠ¥ì„ ë³´ì—¬ì£¼ì—ˆìŠµë‹ˆë‹¤. ë³¸ ì—°êµ¬ì—ì„œëŠ” residual connections ë° ì£¼ì˜ ë©”ì»¤ë‹ˆì¦˜ì„ ê¸°í•˜í•™ì  ê·¸ë˜í”„ í•™ìŠµ í”„ë ˆì„ì›Œí¬ ë‚´ì— í†µí•©í•œ ê¹Šì€ í•©ì„±ê³± ì‹ ê²½ë§ì¸ DeepGGLì„ ì†Œê°œí•©ë‹ˆë‹¤. DeepGGLì€ ë‹¤ì¤‘ ìŠ¤ì¼€ì¼ ê°€ì¤‘ ìƒ‰ìƒ ì´ë¶„ ê·¸ë˜í”„ë¥¼ í™œìš©í•˜ì—¬ ë‹¨ë°±ì§ˆ-ë¦¬ê°„ë“œ ë³µí•©ì²´ì—ì„œ ì›ì ìˆ˜ì¤€ì˜ ì„¸ë°€í•œ ìƒí˜¸ ì‘ìš©ì„ íš¨ê³¼ì ìœ¼ë¡œ í¬ì°©í•©ë‹ˆë‹¤. ìš°ë¦¬ëŠ” CASF-2013 ë° CASF-2016ì—ì„œ DeepGGLì„ ê¸°ì¡´ ëª¨ë¸ê³¼ ë¹„êµí•˜ì—¬ ë‹¤ì–‘í•œ í‰ê°€ ì§€í‘œì—ì„œ í˜ì‹ ì ì¸ ì„±ëŠ¥ì„ ë‹¬ì„±í–ˆìŠµë‹ˆë‹¤. ë” ë‚˜ì•„ê°€ ëª¨ë¸ì˜ ê²¬ê³ ì„±ê³¼ ì¼ë°˜í™”ë¥¼ í‰ê°€í•˜ê¸° ìœ„í•´ CSAR-NRC-HiQ ë°ì´í„°ì…‹ ë° PDBbind v2019 holdout ì„¸íŠ¸ì—ì„œ ëª¨ë¸ì„ í…ŒìŠ¤íŠ¸í–ˆìŠµë‹ˆë‹¤. DeepGGLì€ ì¼ê´€ë˜ê²Œ ë†’ì€ ì˜ˆì¸¡ ì •í™•ë„ë¥¼ ìœ ì§€í•˜ì—¬ êµ¬ì¡° ê¸°ë°˜ ì•½ë¬¼ ë°œê²¬ì—ì„œì˜ ê²°í•© ì¹œí™”ë„ ì˜ˆì¸¡ì— ëŒ€í•œ ì ì‘ì„±ê³¼ ì‹ ë¢°ì„±ì„ ê°•ì¡°í–ˆìŠµë‹ˆë‹¤.

## ğŸ“ ìš”ì•½

ë³¸ ì—°êµ¬ëŠ” ë‹¨ë°±ì§ˆ ìˆ˜ìš©ì²´ì™€ í›„ë³´ ë¦¬ê°„ë“œ ê°„ì˜ ê²°í•© ì¹œí™”ë„ë¥¼ ì •í™•íˆ ì˜ˆì¸¡í•˜ëŠ” ê²ƒì´ ì¤‘ìš”í•œ ë„ì „ ê³¼ì œì´ë©°, ìµœê·¼ ì¸ê³µì§€ëŠ¥ì˜ ë°œì „ìœ¼ë¡œ ê¹Šì€ í•™ìŠµì´ ì „í†µì ì¸ ê²½í—˜ì  ë° ë¬¼ë¦¬í•™ ê¸°ë°˜ ë°©ë²•ë³´ë‹¤ ìš°ìˆ˜í•œ ì„±ëŠ¥ì„ ë³´ì´ê³  ìˆë‹¤. ë³¸ ì—°êµ¬ì—ì„œëŠ” DeepGGLì´ë¼ëŠ” ê¹Šì€ í•©ì„±ê³± ì‹ ê²½ë§ì„ ì†Œê°œí•˜ë©°, ê¸°í•˜í•™ì  ê·¸ë˜í”„ í•™ìŠµ í”„ë ˆì„ì›Œí¬ ë‚´ì—ì„œ ì”ì—¬ ì—°ê²°ê³¼ ì£¼ì˜ ë©”ì»¤ë‹ˆì¦˜ì„ í†µí•©ì‹œì¼°ë‹¤. DeepGGLì€ ë‹¤ì–‘í•œ í‰ê°€ ë©”íŠ¸ë¦­ì„ í†µí•´ CASF-2013 ë° CASF-2016ì—ì„œ ìµœì²¨ë‹¨ ì„±ëŠ¥ì„ ë‹¬ì„±í•˜ì˜€ìœ¼ë©°, CSAR-NRC-HiQ ë°ì´í„°ì…‹ê³¼ PDBbind v2019 í™€ë“œì•„ì›ƒ ì„¸íŠ¸ì—ì„œë„ ë†’ì€ ì˜ˆì¸¡ ì •í™•ë„ë¥¼ ìœ ì§€í•˜ë©° ì•ˆì •ì„±ê³¼ ì¼ë°˜í™” ëŠ¥ë ¥ì„ ì…ì¦í•˜ì˜€ë‹¤. ì´ëŠ” DeepGGLì´ êµ¬ì¡° ê¸°ë°˜ ì•½ë¬¼ ë°œê²¬ì—ì„œ ê²°í•© ì¹œí™”ë„ ì˜ˆì¸¡ì— ëŒ€í•œ ì ì‘ì„±ê³¼ ì‹ ë¢°ì„±ì„ ê°–ì¶”ê³  ìˆìŒì„ ê°•ì¡°í•œë‹¤.

## ğŸ¯ ì£¼ìš” í¬ì¸íŠ¸


- ë‹¨ë°±ì§ˆ ìˆ˜ìš©ì²´ì™€ í›„ë³´ ë¦¬ê°„ë“œ ê°„ì˜ ê²°í•© íš¨ëŠ¥ì„ ì •í™•í•˜ê²Œ ì˜ˆì¸¡í•˜ëŠ” ê²ƒì€ êµ¬ì¡° ê¸°ë°˜ ì•½ë¬¼ ë””ìì¸ì—ì„œ ì¤‘ìš”í•œ ê³¼ì œì´ë‹¤.

- DeepGGLì€ ê¹Šì€ ì»¨ë³¼ë£¨ì…˜ ì‹ ê²½ë§ì„ ì‚¬ìš©í•˜ì—¬ ë‹¨ë°±ì§ˆ-ë¦¬ê°„ë“œ ë³µí•©ì²´ì˜ ì›ì ìˆ˜ì¤€ ìƒí˜¸ì‘ìš©ì„ íš¨ê³¼ì ìœ¼ë¡œ í¬ì°©í•œë‹¤.

- DeepGGLì€ CASF-2013 ë° CASF-2016ì—ì„œ ìµœì²¨ë‹¨ ì„±ëŠ¥ì„ ë‹¬ì„±í•˜ë©° ë‹¤ì–‘í•œ í‰ê°€ ì§€í‘œì—ì„œ ìƒë‹¹í•œ ê°œì„ ì„ ë³´ì—¬ì¤€ë‹¤.

- DeepGGLì€ CSAR-NRC-HiQ ë°ì´í„°ì…‹ê³¼ PDBbind v2019 holdout setì—ì„œë„ ë†’ì€ ì˜ˆì¸¡ ì •í™•ë„ë¥¼ ìœ ì§€í•˜ë©° êµ¬ì¡° ê¸°ë°˜ ì•½ë¬¼ ë°œê²¬ì—ì„œì˜ ê²°í•© íš¨ëŠ¥ ì˜ˆì¸¡ì— ëŒ€í•œ ì‹ ë¢°ì„±ì„ ê°•ì¡°í•œë‹¤.


---

*Generated on 2025-09-18 16:42:33*